Source link : https://newshealth.biz/health-news/sglt2i-show-cardiorenal-liver-benefits-in-cirrhosis/
In patients with type 2 diabetes and cirrhosis, SGLT2 inhibitors show increased efficacy over DPP-4 inhibitors in kidney, cardiac, and liver outcomes. Medscape Medical News Source link : https://www.medscape.com/viewarticle/sglt2-inhibitors-show-cardiorenal-liver-benefits-cirrhosis-2026a1000a7n?src=rss Author : Publish date : 2026-04-03 10:26:00 Copyright for syndicated content belongs to the linked Source.
The post SGLT2i Show Cardiorenal, Liver Benefits in Cirrhosis first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-03 10:26:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8